- U.S Government signs a deal with Regeneron Pharmaceuticals.
- A $450 million contract has been signed between the two parties.
- The deal is for supplying a double antibody cocktail drug for COVID-19.
- The name of the drug is REGN-COV2.
The U.S government has signed a deal with Regeneron Pharmaceuticals Inc. (REGN.O). On Tuesday, the U.S Departm....
Tags : USA, GOVERNMENT, PHARMACEUTICALS, REGENERON, COVID-19, THERAPY,